The most recent FDA approval belongs to BCG plus N-803, which has an initial complete response of 62%, falling to just 36% at 12 months. For technologies currently under clinical evaluation, ...
Dysregulated cell signaling underlies various diseases, emphasizing the importance of understanding these pathways for ...
The agency long benefited from broad bipartisan support. But Republican criticism has intensified, and new choices for top ...
Doctors are seeing a troubling rise in colorectal cancer cases among young adults under 50. Once considered a disease ...
A new total-body PET scanner that is quicker for the patient and produces higher quality images for faster and earlier ...
In this Comment, Ben-Aharon et al. advocate for the creation of designated OncoYoung programs to address the unique needs of individuals with early-onset cancer, as well as multinational platforms ...
The Express joined Peter Kyle on a visit to St Thomas' Hospital where the cutting-edge technology is being harnessed.
New York City’s network of academic medical centers has driven construction of outpatient facilities in recent years, ...
Elekta Evo, our latest AI-powered adaptive CT-Linac and Elekta ONE Planning has been launched at ASTRO and, in the quarter, also at ASTRO in Washington. Customer feedback has been very encouraging and ...
Once inside the body, HIV persists because of its remarkable ability to hide within healthy CD4 T cells, where it can lie ...
March-in rights are vital safeguards that allow the federal government to license competitors when the owner is not making a ...